Abstract
Background
The high mortality associated with drug-resistant bacterial infections is an intractable clinical problem resulting from the low susceptibility of these bacteria to antibiotics and the high incidence of recurrent infections.
Methods
Herein, a photosynthetic bacteria-based multiplex system (Rp@Al) composed of natural Rhodopseudomonas palustris (Rp) and Food and Drug Administration-approved aluminum (Al) adjuvant, was developed to combat drug-resistant bacterial infections and prevent their recurrence. We examined its photothermal performance and in vitro and in vivo antibacterial ability; revealed its protective immunomodulatory effect; verified its preventative effect on recurrent infections; and demonstrated the system’s safety.
Results
Rp@Al exhibits excellent photothermal properties with an effective elimination of methicillin-resistant Staphylococcus aureus (MRSA). In addition, Rp@Al enhances dendritic cell activation and further triggers a T helper 1 (TH1)/TH2 immune response, resulting in pathogen-specific immunological memory against recurrent MRSA infection. Upon second infection, Rp@Al-treated mice show significantly lower bacterial burden, faster abscess recovery, and higher survival under near-lethal infection doses than control mice.
Conclusions
This innovative multiplex system, with superior photothermal and immunomodulatory effects, presents great potential for the treatment and prevention of drug-resistant bacterial infections.
Graphical Abstract
![](http://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40824-023-00363-0/MediaObjects/40824_2023_363_Figa_HTML.png)
Similar content being viewed by others
Background
In clinics, antibiotics are the preferred line of treatment for bacterial infections. However, their misuse has resulted in the emergence and rapid increase of multidrug-resistant pathogens [1,2,3,4]. A comprehensive study of 204 countries and territories estimated that there were 4.95 million deaths associated with antimicrobial resistance (AMR), which has become the third leading cause of death worldwide [5]. Furthermore, a review on AMR, commissioned by the UK government, reported that AMR-related deaths will exceed 10 million annually by 2050, surpassing cancer-related deaths [6]. The high mortality associated with drug-resistant bacterial infections is ascribed not only to the low susceptibility of these bacteria to antibiotics, but also to the high incidence of recurrent infections [7, 8]. Methicillin-resistant Staphylococcus aureus (MRSA), with a high risk of recurrence, is one of the most common drug-resistant bacteria in bacteremia, endocarditis, skin and soft tissue infections, bone and joint infections, and hospital-acquired infections [9]. Therefore, it is imperative to develop non-antibiotic therapies that integrate treatment and prevention against drug-resistant bacteria and their recurrent infections.
Bacteria-mediated therapies have attracted remarkable attention in recent years [10,11, In summary, we presented a multiplex system that utilizes photothermal ablation to achieve drug-resistant bacteria abrogation, while also preventing recurrent infections with drug-resistant bacteria through adjuvant-like modulation of the host immune response. Specifically, we i) developed a PSB-based multiplex system (Rp@Al) that was fabricated through electrostatic-driven self-assembly for combating drug-resistant bacterial infections; ii) demonstrated that Rp@Al, containing BChl, which absorbs NIR light at around 805 and 865 nm, exhibited prominent photothermal properties and photothermal ablation ability toward drug-resistant bacteria; iii) revealed that Rp@Al exerts an adjuvant-like effect to enhance the antigen presentation of activated DCs, thereby priming TH1/TH2 immune responses, resulting in a protective pathogen-specific immunological memory against recurrent infections with drug-resistant bacteria; and iv) illustrated that Rp@Al not only eliminates drug-resistant bacteria through photothermal killing but also plays a preventive role in reducing infection burden and prolonging the survival period of mice during recurrent infections (Fig. 7). Schematic illustration of PSB-based multiplex system for the treatment of drug-resistant bacterial infections. Photosynthetic bacteria (PSB)-based Rp@Al, fabricated through an electrostatic-driven self-assembly process, containing bacteriochlorophyll (BChl) that absorbs near-infrared (NIR) light at around 805 and 865 nm, exhibited effective photothermal ablation of MRSA. Rp@Al also exerted an adjuvant-like effect to enhance the antigen presentation of activated DCs, thereby priming the T helper 1 (TH1)/TH2 immune response, resulting in a protective pathogen-specific immunological memory against recurrent infections with the same drug-resistant bacteriaConclusions
Availability of data and materials
The data that support the findings of this study are available from the corresponding authors upon reasonable request.
Abbreviations
- AMR:
-
Antimicrobial resistance
- MRSA :
-
Methicillin-resistant Staphylococcus aureus
- PSB:
-
Photosynthetic bacteria
- BChl:
-
Bacteriochlorophyll
- NIR:
-
Near-infrared
- PRRs:
-
Pattern recognition receptors
- TLRs:
-
Toll-like receptors
- NLRs:
-
NOD-like receptors
- BHI:
-
Brain Heart Infusion
- IFNγ:
-
Interferon γ
- IL:
-
Interleukin
- ELISA:
-
Enzyme-linked immunosorbent assay
- ALT:
-
Alanine aminotransferase
- AST:
-
Aspartate aminotransferase
- CRE:
-
Creatinine
- BUN:
-
Blood urea nitrogen
- TC:
-
Total cholesterol
- TG:
-
Triglyceride
- GLU:
-
Glucose
- Rp:
-
Rhodopseudomonas palustris
- PBS:
-
Phosphate-buffered saline
- PFA:
-
Paraformaldehyde
- DCs:
-
Dendritic cells
- H&E:
-
Hematoxylin and eosin
References
Baym M, Stone LK, Kishony R. Multidrug evolutionary strategies to reverse antibiotic resistance. Science. 2016;351:aad3292. https://doi.org/10.1126/science.aad3292.
Theuretzbacher U, Outterson K, Engel A, Karlén A. The global preclinical antibacterial pipeline. Nat Rev Microbiol. 2020;18:275–85. https://doi.org/10.1038/s41579-019-0288-0.
Lewis K. The science of antibiotic discovery. Cell. 2020;181:29–45. https://doi.org/10.1016/j.cell.2020.02.056.
Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74:417–33. https://doi.org/10.1128/MMBR.00016-10.
Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55. https://doi.org/10.1016/S0140-6736(21)02724-0.
O’Neill J. Tackling drug-resistant infections globally: final report and recommendations, Rev Antimicrob Resist. 2016. https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf.
Schrader SM, Vaubourgeix J, Nathan C. Biology of antimicrobial resistance and approaches to combat it. Sci Transl Med. 2020;12:eaaz6992. https://doi.org/10.1126/scitranslmed.aaz6992.
Wu Y, Jiang W, Huo S, Li S, Xu Y, Ding S, et al. Nano-metal–organic-frameworks for treating H2O2-secreting bacteria alleviate pulmonary injury and prevent systemic sepsis. Biomaterials. 2021;279:121237. https://doi.org/10.1016/j.biomaterials.2021.121237.
Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol. 2019;17:203–18. https://doi.org/10.1038/s41579-018-0147-4.
Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science. 2000;289:1352–5. https://doi.org/10.1126/science.289.5483.1352.
Tan L, Fu J, Feng F, Liu X, Cui Z, Li B, et al. Engineered probiotics biofilm enhances osseointegration via immunoregulation and anti-infection. Sci Adv. 2020;6:eaba5723. https://doi.org/10.1126/sciadv.aba5723.
Yi X, Zhou H, Chao Y, **ong S, Zhong J, Chai Z, et al. Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer. Sci Adv. 2020;6:eaba3546. https://doi.org/10.1126/sciadv.aba3546.
Chen Q-W, Liu X, Fan J-X, Peng S, Wang J, Wang X, et al. Self-mineralized photothermal bacteria hybridizing with mitochondria-targeted metal–organic frameworks for augmenting photothermal tumor therapy. Adv Funct Mater. 2020;30:1909806. https://doi.org/10.1002/adfm.201909806.
Zhong D, Li W, Qi Y, He J, Zhou M. Photosynthetic biohybrid nanoswimmers system to alleviate tumor hypoxia for FL/PA/MR imaging-guided enhanced radio-photodynamic synergetic therapy. Adv Funct Mater. 2020;30:1910395. https://doi.org/10.1002/adfm.201910395.
Li W, Wang S, Zhong D, Du Z, Zhou M. A bioactive living hydrogel: photosynthetic bacteria mediated hypoxia elimination and bacteria-killing to promote infected Wound healing. Adv Therap. 2021;4:2000107. https://doi.org/10.1002/adtp.202000107.
Wang S-B, Liu X-H, Li B, Fan J, Ye J, Cheng H, et al. Bacteria-assisted selective photothermal therapy for precise tumor inhibition. Adv Funct Mater. 2019;29:1904093. https://doi.org/10.1002/adfm.201904093.
Qiao Y, Yang F, **e T, Du Z, Zhong D, Qi Y, et al. Engineered algae: a novel oxygen-generating system for effective treatment of hypoxic cancer. Sci Adv. 2020;6:eaba5996. https://doi.org/10.1126/sciadv.aba5996.
Zhong D, Zhang D, **e T, Zhou M. Biodegradable microalgae-based carriers for targeted delivery and imaging-guided therapy toward lung metastasis of breast cancer. Small. 2020;16:e2000819. https://doi.org/10.1002/smll.202000819.
Riglar DT, Silver PA. Engineering bacteria for diagnostic and therapeutic applications. Nat Rev Microbiol. 2018;16:214–25. https://doi.org/10.1038/nrmicro.2017.172.
Huang X, Pan J, Xu F, Shao B, Wang Y, Guo X, et al. Bacteria-based cancer immunotherapy. Adv Sci (Weinh). 2021;8:2003572. https://doi.org/10.1002/advs.202003572.
Zheng JH, Nguyen VH, Jiang SN, Park SH, Tan W, Hong SH, et al. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Sci Transl Med. 2017;9:eaak9537. https://doi.org/10.1126/scitranslmed.aak9537.
Gao C, Wang Q, Li J, Kwong CHT, Wei J, **e B, et al. In vivo hitchhiking of immune cells by intracellular self-assembly of bacteria-mimetic nanomedicine for targeted therapy of melanoma. Sci Adv. 2022;8:eabn1805. https://doi.org/10.1126/sciadv.abn1805.
Chowdhury S, Castro S, Coker C, Hinchliffe TE, Arpaia N, Danino T. Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nat Med. 2019;25:1057–63. https://doi.org/10.1038/s41591-019-0498-z.
Zheng DW, Chen Y, Li ZH, Xu L, Li CX, Li B, et al. Optically controlled bacterial metabolite for cancer therapy. Nat Commun. 2018;9:1680. https://doi.org/10.1038/s41467-018-03233-9.
Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2010;7:503–14. https://doi.org/10.1038/nrgastro.2010.117.
Liévin-Le Moal VL-L, Servin AL. Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clin Microbiol Rev. 2014;27:167–99. https://doi.org/10.1128/CMR.00080-13.
Liu X, Huang L, Rensing C, Ye J, Nealson KH, Zhou S. Syntrophic interspecies electron transfer drives carbon fixation and growth by Rhodopseudomonas palustris under dark, anoxic conditions. Sci Adv. 2021;7:eabn1852. https://doi.org/10.1126/sciadv.abh1852.
Lu H, Zhang G, Wan T, Lu Y. Influences of light and oxygen conditions on photosynthetic bacteria macromolecule degradation: different metabolic pathways. Bioresour Technol. 2011;102:9503–8. https://doi.org/10.1016/j.biortech.2011.07.114.
Lu H, Zhang G, Zheng Z, Meng F, Du T, He S. Bio-conversion of photosynthetic bacteria from non-toxic wastewater to realize wastewater treatment and bioresource recovery: a review. Bioresour Technol. 2019;278:383–99. https://doi.org/10.1016/j.biortech.2019.01.070.
Shu X, Royant A, Lin MZ, Aguilera TA, Lev-Ram V, Steinbach PA, et al. Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science. 2009;324:804–7. https://doi.org/10.1126/science.1168683.
Ryu MH, Kang IH, Nelson MD, Jensen TM, Lyuksyutova AI, Siltberg-Liberles J, et al. Engineering adenylate cyclases regulated by near-infrared window light. Proc Natl Acad Sci U S A. 2014;111:10167–72. https://doi.org/10.1073/pnas.1324301111.
Zheng P, Fan M, Liu H, Zhang Y, Dai X, Li H, et al. Self-propelled and near-infrared-phototaxic photosynthetic bacteria as photothermal agents for hypoxia-targeted cancer therapy. ACS Nano. 2021;15:1100–10. https://doi.org/10.1021/acsnano.0c08068.
Makabenta JMV, Nabawy A, Li CH, Schmidt-Malan S, Patel R, Rotello VM. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. Nat Rev Microbiol. 2021;19:23–36. https://doi.org/10.1038/s41579-020-0420-1.
Guo B, Huang Z, Shi Q, Middha E, Xu S, Li L, et al. Organic small molecule based photothermal agents with molecular rotors for malignant breast cancer therapy. Adv Funct Mater. 2020;30:1907093. https://doi.org/10.1002/adfm.201907093.
Zhang L, Liu Y, Huang H, **e H, Zhang B, **a W, et al. Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors. Adv Drug Deliv Rev. 2022;190:114536. https://doi.org/10.1016/j.addr.2022.114536.
Zhang L, Forgham H, Huang X, Shen A, Davis TP, Qiao R, et al. All-in-one inorganic nanoagents for near-infrared-II photothermal-based cancer theranostics. Materials Today Advances. 2022;14:100226. https://doi.org/10.1016/j.mtadv.2022.100226.
Hancock REW, Nijnik A, Philpott DJ. Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol. 2012;10:243–54. https://doi.org/10.1038/nrmicro2745.
Pernet E, Guillemot L, Burgel PR, Martin C, Lambeau G, Sermet-Gaudelus I, et al. Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity. Nat Commun. 2014;5:5105. https://doi.org/10.1038/ncomms6105.
Kim B, Pang HB, Kang J, Park JH, Ruoslahti E, Sailor MJ. Immunogene therapy with fusogenic nanoparticles modulates macrophage response to Staphylococcus aureus. Nat Commun. 2018;9:1969. https://doi.org/10.1038/s41467-018-04390-7.
Tang H, Qu X, Zhang W, Chen X, Zhang S, Xu Y, et al. Photosensitizer nanodot eliciting immunogenicity for photo-immunologic therapy of postoperative methicillin-resistant Staphylococcus aureus infection and secondary recurrence. Adv Mater. 2022;34:e2107300. https://doi.org/10.1002/adma.202107300.
Fu J, Li Y, Zhang Y, Liang Y, Zheng Y, Li Z, et al. An engineered pseudo-macrophage for rapid treatment of bacteria-infected osteomyelitis via microwave-excited anti-infection and immunoregulation. Adv Mater. 2021;33:e2102926. https://doi.org/10.1002/adma.202102926.
Wei X, Ran D, Campeau A, **ao C, Zhou J, Dehaini D, et al. Multiantigenic nanotoxoids for antivirulence vaccination against antibiotic-resistant gram-negative bacteria. Nano Lett. 2019;19:4760–9. https://doi.org/10.1021/acs.nanolett.9b01844.
Wang C, **ao Y, Zhu W, Chu J, Xu J, Zhao H, et al. Photosensitizer-modified MnO2 nanoparticles to enhance photodynamic treatment of abscesses and boost immune protection for treated mice. Small. 2020;16:e2000589. https://doi.org/10.1002/smll.202000589.
Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151–60. https://doi.org/10.1056/NEJMoa021481.
Hennessy EJ, Parker AE, O’Neill LAJ. Targeting toll-like receptors: emerging therapeutics? Nat Rev Drug Discov. 2010;9:293–307. https://doi.org/10.1038/nrd3203.
Sorbara MT, Philpott DJ. Peptidoglycan: a critical activator of the mammalian immune system during infection and homeostasis. Immunol Rev. 2011;243:40–60. https://doi.org/10.1111/j.1600-065X.2011.01047.x.
Dunne A, O’Neill LAJ. The interleukin-1 receptor/toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE. 2003;2003:re3. https://doi.org/10.1126/stke.2003.171.re3.
Zaheer SA, Mukherjee R, Ramkumar B, Misra RS, Sharma AK, Kar HK, et al. Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy. J Infect Dis. 1993;167:401–10. https://doi.org/10.1093/infdis/167.2.401.
Klinman DM, **e H, Ivins BE. CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine. Ann N Y Acad Sci. 2006;1082:137–50. https://doi.org/10.1196/annals.1348.030.
Marrack P, McKee AS, Munks MW. Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol. 2009;9:287–93. https://doi.org/10.1038/nri2510.
Eisenbarth SC, Colegio OR, O’Connor W, Sutterwala FS, Flavell RA. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 2008;453:1122–6. https://doi.org/10.1038/nature06939.
Jiang H, Wang Q, Li L, Zeng Q, Li H, Gong T, et al. Turning the old adjuvant from gel to nanoparticles to amplify CD8+ T cell responses. Adv Sci (Weinh). 2018;5:1700426. https://doi.org/10.1002/advs.201700426.
Hessel CM, Pattani VP, Rasch M, Panthani MG, Koo B, Tunnell JW, et al. Copper selenide nanocrystals for photothermal therapy. Nano Lett. 2011;11:2560–6. https://doi.org/10.1021/nl201400z.
Li Y, Bai G, Zeng S, Hao J. Theranostic carbon dots with innovative NIR-II emission for in vivo renal-excreted optical imaging and photothermal therapy. ACS Appl Mater Interfaces. 2019;11:4737–44. https://doi.org/10.1021/acsami.8b14877.
Sun Z, **e H, Tang S, Yu XF, Guo Z, Shao J, et al. Ultrasmall black phosphorus quantum dots: synthesis and use as photothermal agents. Angew Chem Int Ed Engl. 2015;54:11526–30. https://doi.org/10.1002/anie.201506154.
Ding Y, Wang C, Lu B, Yao Y. Enhancing the stability and photothermal conversion efficiency of ICG by pillar[5]arene-Based Host-Guest Interaction. Front Chem. 2021;9:775436. https://doi.org/10.3389/fchem.2021.775436.
Bellier N, Baipaywad P, Ryu N, Lee JY, Park H. Recent biomedical advancements in graphene oxide- and reduced graphene oxide-based nanocomposite nanocarriers. Biomater Res. 2022;26:65. https://doi.org/10.1186/s40824-022-00313-2.
Huang H, Ali A, Liu Y, **e H, Ullah S, Roy S, et al. Advances in image-guided drug delivery for antibacterial therapy. Adv Drug Deliv Rev. 2023;192:114634. https://doi.org/10.1016/j.addr.2022.114634.
Quintero-Quiroz C, Acevedo N, Zapata-Giraldo J, Botero LE, Quintero J, Zárate-Triviño D, et al. Optimization of silver nanoparticle synthesis by chemical reduction and evaluation of its antimicrobial and toxic activity. Biomater Res. 2019;23:1–15. https://doi.org/10.1186/s40824-019-0173-y.
Abebe F. Synergy between Th1 and Th2 responses during Mycobacterium tuberculosis infection: a review of current understanding. Int Rev Immunol. 2019;38:172–9. https://doi.org/10.1080/08830185.2019.1632842.
Mullard A. The deadly burden of drug-resistant bacteria. Nat Rev Drug Discov. 2022;21:170. https://doi.org/10.1038/d41573-022-00034-0.
Zhu Y, Hao W, Wang X, Ouyang J, Deng X, Yu H, et al. Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections. Med Res Rev. 2022;42:1377–422. https://doi.org/10.1002/med.21879.
Acknowledgements
We acknowledge the Anhui Center for Surveillance of Bacterial Resistance for providing the MRSA strain and the China Center of Industrial Culture Collection for providing the Rp strain.
Funding
This work was supported by the National Natural Science Foundation of China [grant numbers 81871788 and 32171375]; the Outstanding Youth Fund of Natural Science Foundation of Anhui Province [grant number 2108085J41]; the Key Research and Development Program of Anhui Province [grant number 202004j07020013]; the Anhui Provincial Postdoctoral Science Foundation [grant number 2019 B302]; the Scientific Research Fund of Anhui Education Office [grant number 2020jyxm2316]; and the Anhui Province Natural Science Foundation (grant numbers 1908085MH263).
Author information
Authors and Affiliations
Ethics declarations
Ethics approval and consent to participate
All animal experiments were approved by the Animal Ethics Committee of Guangdong Provincial People’s Hospital (Approval No. KY-Q-2022–197-01).
Consent for publication
All authors agree to be published.
Competing interests
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Additional file 1: Fig. S1.
Stability of Rp@Al on days 0, 3, and 7. Fig. S2. The preparation mechanism of Rp@Al. Fig. S3. Statistical analysis of scanning electron microscopy (SEM) images of Rp showing its diameter distribution. Fig. S4. Representative image of a growing Rp culture. Fig. S5. Time-lapse images showing the photothermal conversion of PBS, Rp, and Rp@Al. Fig. S6. Time-lapse images showing the photothermal conversion of PBS and different concentrations of Rp@Al. Fig. S7. Time-lapse images showing the photothermal conversion of Rp@Al using an 808-nm laser. Fig. S8. Levels of reactive oxygen species in methicillin-resistant Staphylococcus aureus (MRSA) after different treatment. Fig. S9. Temperature monitoring of the abscess site in mice under 808 nm laser irradiation. Fig. S10. Quantitative analysis showing collagen deposition levels in different treatment groups. Fig. S11. Representative flow scatter plot showing the percentage of CD4+ T cells in total leukocytes. Fig. S12. Comparative analysis of the proportion of memory B cells in mice from different treatment groups. Fig. S13. Time-lapse images showing the abscess recovery in treatment groups after second subcutaneous injection of MRSA. Fig. S14. The abscess recovery in different treatment groups after a second subcutaneous infection of MRSA. Fig. S15. Weight of the mice before intravenous re-infection with MRSA. Table S1. Summary of the photothermal conversion efficiency (η) of some photothermal agents that have been reported. Table S2. Summary of the pros and cons for different nanomaterials for antibacterial applications.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Xu, Y., Wu, Y., Hu, Y. et al. Bacteria-based multiplex system eradicates recurrent infections with drug-resistant bacteria via photothermal killing and protective immunity elicitation. Biomater Res 27, 27 (2023). https://doi.org/10.1186/s40824-023-00363-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40824-023-00363-0